AU4575299A - Compositions for increasing energy (in vivo) - Google Patents
Compositions for increasing energy (in vivo) Download PDFInfo
- Publication number
- AU4575299A AU4575299A AU45752/99A AU4575299A AU4575299A AU 4575299 A AU4575299 A AU 4575299A AU 45752/99 A AU45752/99 A AU 45752/99A AU 4575299 A AU4575299 A AU 4575299A AU 4575299 A AU4575299 A AU 4575299A
- Authority
- AU
- Australia
- Prior art keywords
- ribose
- pentose
- atp
- mammal
- energy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9000198P | 1998-06-19 | 1998-06-19 | |
| US60090001 | 1998-06-19 | ||
| US09290789 | 1999-04-12 | ||
| US09/290,789 US6159942A (en) | 1998-06-19 | 1999-04-12 | Compositions for increasing energy in vivo |
| PCT/US1999/013720 WO1999065476A2 (en) | 1998-06-19 | 1999-06-17 | COMPOSITIONS FOR INCREASING ENERGY $i(IN VIVO) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4575299A true AU4575299A (en) | 2000-01-05 |
Family
ID=26781174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU45752/99A Abandoned AU4575299A (en) | 1998-06-19 | 1999-06-17 | Compositions for increasing energy (in vivo) |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6159942A (cg-RX-API-DMAC7.html) |
| EP (1) | EP1087779B1 (cg-RX-API-DMAC7.html) |
| JP (5) | JP2002518321A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1306431A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE534393T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU4575299A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2334415C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2374260T3 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ508478A (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999065476A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020119933A1 (en) * | 2000-07-28 | 2002-08-29 | Butler Terri L. | Compositions and methods for improving cardiovascular function |
| US6339716B1 (en) * | 1999-09-24 | 2002-01-15 | Bioenergy Inc. | Method for determining viability of a myocardial segment |
| US6159943A (en) * | 1999-09-24 | 2000-12-12 | Bioenergy, Inc. | Use of ribose to prevent cramping and soreness in muscles |
| US6511964B2 (en) | 1999-09-24 | 2003-01-28 | Bioenergy, Inc. | Method for treating acute mountain sickness |
| US6703370B1 (en) * | 1999-10-27 | 2004-03-09 | Bioenergy, Inc. | Use of ribose to treat fibromyalgia |
| GB2353217B (en) * | 1999-10-27 | 2001-07-18 | Bioenergy Inc | Use of ribose to treat fibromyalgia |
| AU1800801A (en) * | 1999-11-17 | 2001-05-30 | Eric H. Kuhrts | Exercise and muscle enhancement formulations |
| AU2594001A (en) | 1999-12-21 | 2001-07-03 | Bioenergy Inc. | Compositions for the storage of platelets |
| GB2364642B (en) * | 2000-01-07 | 2004-10-27 | Bioenergy Inc | Compositions for enhancing the immune response |
| AU2001229672A1 (en) | 2000-01-20 | 2001-07-31 | Bioenergy Inc. | Use of ribose supplementation for increasing muscle mass and decreasing body fatin humans |
| US6553254B1 (en) * | 2000-04-07 | 2003-04-22 | Keith E. Kenyon | Combination of non-living-source physical energy and living-source chemical energy to maximize the salvage of ATP |
| US6835750B1 (en) | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
| US6420342B1 (en) * | 2000-05-08 | 2002-07-16 | N.V. Nutricia | Nutritional preparation comprising ribose and medical use thereof |
| IT1317043B1 (it) | 2000-06-14 | 2003-05-26 | Sigma Tau Healthscience Spa | Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio. |
| JP2004505056A (ja) * | 2000-07-28 | 2004-02-19 | バイオエナジー インコーポレイティド | 心血管の機能を向上する為の組成物及び方法 |
| US6855727B2 (en) * | 2000-12-04 | 2005-02-15 | Yaizu Suisankagaku Industry Co., Ltd. | Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect |
| EP1247525A1 (en) * | 2001-04-02 | 2002-10-09 | Bioenergy Inc. | Use of a monosaccharide in the manufacture of a medicament against acute mountain sickness |
| US7629329B2 (en) * | 2001-06-04 | 2009-12-08 | Tsi Health Sciences, Inc. | Method for increasing muscle mass and strength through administration of adenosine triphosphate |
| GB2381451A (en) * | 2001-11-01 | 2003-05-07 | New Technology Res Ltd | Pharmaco-dietary preparation having nutrition-supplementing and nutrition-enhancing effect |
| DE10215007A1 (de) * | 2002-04-05 | 2003-10-16 | Degussa Bioactives Deutschland | Verwendung von Kreatinpyruvat zur Steigerung der Ausdauer bei hochintensiven körperlichen Intervallbelastungen |
| US7547450B2 (en) * | 2002-10-24 | 2009-06-16 | Nestec Ltd. | Senior feline food |
| US6838562B2 (en) * | 2003-04-01 | 2005-01-04 | Sal Abraham | Process for preparing a creatine heterocyclic acid salt and method of use |
| US7687468B2 (en) * | 2003-05-14 | 2010-03-30 | Viacell, LLC. | Rejuvenation of stored blood |
| US8759315B2 (en) * | 2003-05-14 | 2014-06-24 | Viacell, Llc | Methods for rejuvenating |
| US20040229205A1 (en) * | 2003-05-16 | 2004-11-18 | Ericson Daniel G. | Compositions for the storage of platelets |
| BRPI0506485A (pt) * | 2004-01-14 | 2007-02-13 | Bioenergy Inc | método para reduzir o tempo de recuperação de um mamìfero submetido a uma anestesia geral, método para aumentar a recuperação de sepsia e uma composição adequada para administração intravenosa |
| EP1734974A1 (en) * | 2004-03-18 | 2006-12-27 | Tanabe Seiyaku Co., Ltd. | D-ribose for improving depression-like symptoms |
| JP2005336176A (ja) * | 2004-04-28 | 2005-12-08 | Tanabe Seiyaku Co Ltd | 肉体疲労改善剤 |
| US20100099630A1 (en) * | 2004-04-29 | 2010-04-22 | Maccarter Dean J | Method for improving ventilatory efficiency |
| WO2005107768A2 (en) | 2004-04-29 | 2005-11-17 | Bioenergy, Inc. | Method for improving ventilatory efficiency |
| US7968138B2 (en) * | 2004-07-23 | 2011-06-28 | Arnold Nerenberg | Food sweetener |
| US20060029644A1 (en) * | 2004-08-06 | 2006-02-09 | Kenyon Keith E | In vitro biochemical reactions with free anhydrous D-ribose |
| WO2007001883A2 (en) * | 2005-06-20 | 2007-01-04 | Accera, Inc. | Method to reduce oxidative damage and improve mitochondrial efficiency |
| US7566463B2 (en) | 2006-05-03 | 2009-07-28 | C. B. Fleet Company | Oral rehydration compositions |
| US20080146579A1 (en) * | 2006-12-15 | 2008-06-19 | N.V. Nutricia | Treatment of patients with chronic pulmonary diseases and nutritional compositions therefore |
| ATE487485T1 (de) * | 2007-01-23 | 2010-11-15 | Bioenergy Inc | Verwendung von d-ribose zur behandlung von vorhofflimmern |
| US20090197819A1 (en) * | 2007-03-20 | 2009-08-06 | Clarence Albert Johnson | Compositions for improving and repairing skin |
| US20080312169A1 (en) * | 2007-03-20 | 2008-12-18 | Clarence Albert Johnson | Cosmetic use of D-ribose |
| CN101356971B (zh) * | 2007-07-30 | 2012-11-07 | 石药集团中奇制药技术(石家庄)有限公司 | 一种用于抗疲劳耐缺氧的保健食品组合物 |
| EP2179284B1 (en) | 2007-07-31 | 2016-09-28 | Accera, Inc. | Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function |
| US20090061016A1 (en) * | 2007-09-05 | 2009-03-05 | Selzer Jonathan A | Seawater Based Dietary Supplement Product for Energy and Electrolyte Replacement |
| US20090232750A1 (en) * | 2008-03-13 | 2009-09-17 | St Cyr John A | Compositions for indoor tanning |
| CN102387805A (zh) * | 2008-04-02 | 2012-03-21 | 生物能公司 | 核糖在对于急性心肌梗塞的第一反应中的用途 |
| CA2735949C (en) | 2008-05-16 | 2016-04-19 | Bioenergy, Inc. | Use of ribose in lessening the clinical symptoms of aberrant firing of neurons |
| US9125881B2 (en) | 2008-07-03 | 2015-09-08 | Accera, Inc. | Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders |
| JP2012500261A (ja) * | 2008-08-20 | 2012-01-05 | バイオエナジー インコーポレイティド | 疲労した対象のためのd−リボースの使用 |
| IT1391588B1 (it) * | 2008-10-15 | 2012-01-11 | Giellepi Chemicals S P A | Composizione sinergica per il recupero e la riduzione del danno ischemico lieve |
| US8255453B2 (en) | 2009-09-14 | 2012-08-28 | International Business Machines Corporation | Public BOT management in private networks |
| WO2011075185A1 (en) | 2009-12-18 | 2011-06-23 | Oligasis | Targeted drug phosphorylcholine polymer conjugates |
| CA2789709C (en) | 2010-02-16 | 2018-03-20 | Viacell, Llc | Arginine-containing compositions and methods for treating red blood cells |
| US20110229871A1 (en) | 2010-02-16 | 2011-09-22 | Ericson Daniel G | Nucleoside-containing compositions and methods for treating red blood cells |
| CN102058045B (zh) * | 2010-10-26 | 2012-09-19 | 开平牵牛生化制药有限公司 | 一种用于补充人体能量和恢复疲劳的饮品 |
| ES2819217T3 (es) | 2013-09-08 | 2021-04-15 | Kodiak Sciences Inc | Conjugados de polímeros iónicos dipolares y factor VIII |
| BR112016028654A2 (pt) | 2014-06-12 | 2018-07-10 | Lonza Ag | método para diminuição de dano muscular esquelético e / ou estresse oxidativo em mamíferos |
| JP2017537079A (ja) * | 2014-11-03 | 2017-12-14 | バイオエナジー ライフ サイエンス,インコーポレイティド | 身体的ストレスへの適応を強化するためのd−リボースの使用 |
| US10888571B2 (en) | 2015-12-18 | 2021-01-12 | Lonza Consumer Health Inc. | Method and composition for increasing muscle protein synthesis and/or functional strength in mammals |
| EP3411041A1 (en) | 2016-02-01 | 2018-12-12 | RiboCor, Inc. | Use of ribose for treatment of subjects having congestive heart failure |
| CN108433106A (zh) * | 2017-11-07 | 2018-08-24 | 付少才 | 一种耐缺氧活性果糖粉(液)组合物 |
| CA3157509A1 (en) | 2019-10-10 | 2021-04-15 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| JPWO2023135827A1 (cg-RX-API-DMAC7.html) * | 2022-01-13 | 2023-07-20 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6049764A (ja) * | 1983-08-29 | 1985-03-19 | Ajinomoto Co Inc | 食品組成物 |
| JPS6094075A (ja) * | 1983-10-31 | 1985-05-27 | Ajinomoto Co Inc | 果汁飲料組成物 |
| US4605644A (en) * | 1985-02-07 | 1986-08-12 | Regents Of The University Of Minnesota | Method for stimulating recovery from ischemia employing ribose and adenine |
| US4719201A (en) * | 1985-02-07 | 1988-01-12 | Regents Of The University Of Minnesota | Method for stimulating recovery from ischemia |
| US4824660A (en) * | 1985-06-06 | 1989-04-25 | Paul S. Angello | Method of determining the viability of tissue in an organism |
| JPS6232860A (ja) * | 1985-08-06 | 1987-02-12 | Riichiro Yamazaki | 健康食品 |
| US4920098A (en) * | 1986-09-17 | 1990-04-24 | Baxter International Inc. | Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases |
| AU2228888A (en) * | 1987-10-14 | 1989-05-25 | Takeda Chemical Industries Ltd. | Aqueous pharmaceutical preparation for oral administration |
| JPH02212A (ja) * | 1987-10-14 | 1990-01-05 | Takeda Chem Ind Ltd | 経口用水性製剤 |
| US4871718A (en) * | 1987-12-29 | 1989-10-03 | Raymond A. Roncari | Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair |
| US4981687A (en) * | 1988-07-29 | 1991-01-01 | University Of Florida | Compositions and methods for achieving improved physiological response to exercise |
| US4968719A (en) * | 1989-04-03 | 1990-11-06 | Sigma Tau, Industrie Farmaceutiche Riunite Spa | Method for treating vascular disease |
| US5114723A (en) * | 1990-02-27 | 1992-05-19 | University Of Texas System Board Of Regents | Beverage compositions for human consumption |
| FR2668039B1 (fr) * | 1990-10-18 | 1993-06-25 | Pernod Ricard | Boisson dietetique destinee a permettre de soutenir l'effort. |
| IT1247125B (it) * | 1991-03-01 | 1994-12-12 | Depha Team Srl | Composizioni dietetiche o farmaceutiche per il ripristino del contenuto cellulare degli adenin nucleotidi nel muscolo scheletrico e cardiaco. |
| US5292538A (en) * | 1992-07-22 | 1994-03-08 | Metagenics, Inc. | Improved sustained energy and anabolic composition and method of making |
| GB9215746D0 (en) * | 1992-07-24 | 1992-09-09 | Hultman Eric | A method of increasing creatine supply depot |
| DE4228215A1 (de) * | 1992-08-25 | 1994-03-03 | Pliml Wolfgang | Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen |
| US5852058A (en) * | 1993-06-11 | 1998-12-22 | The Board Of Trustees Of The Leland Stanford Junior University | Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury |
| JPH07233070A (ja) * | 1994-02-23 | 1995-09-05 | Taisho Pharmaceut Co Ltd | 疲労改善剤 |
| JP3213666B2 (ja) * | 1994-02-28 | 2001-10-02 | 治彦 末岡 | クレアチン飲料の製造方法 |
| AU1780395A (en) * | 1994-05-02 | 1995-11-09 | Omeara (Proprietary) Limited | Amino acid, carnitine and magnesium supplementation |
| US5536751A (en) * | 1994-05-09 | 1996-07-16 | The United States Of America As Represented By The Secretary Of The Army | Pharmaceutical alpha-keto carboxylic acid compositions method of making and use thereof |
| JPH07330584A (ja) * | 1994-06-08 | 1995-12-19 | Taisho Pharmaceut Co Ltd | 疲労改善剤 |
| GB9517443D0 (en) * | 1994-12-17 | 1995-10-25 | Univ Nottingham | Increasing creatine and glycogen concentration in muscle |
| JP3595373B2 (ja) * | 1995-02-20 | 2004-12-02 | 治彦 末岡 | クレアチン飲料 |
| US5707971A (en) * | 1995-06-07 | 1998-01-13 | Life Resuscitation Technologies, Inc. | Modulation of glycolytic ATP production |
| US5709971A (en) | 1995-06-20 | 1998-01-20 | Eastman Kodak Company | Dye imbibition printing blanks with antistatic layer |
| GB9611356D0 (en) * | 1996-05-31 | 1996-08-07 | Howard Alan N | Improvements in or relating to compositions containing Creatine, and other ergogenic compounds |
| JP3563892B2 (ja) * | 1996-10-08 | 2004-09-08 | 伊藤ハム株式会社 | 体力増強・疲労回復剤及びそれを用いた食品 |
| DE19650755A1 (de) * | 1996-12-06 | 1998-06-10 | Wolfgang Dr Pliml | Anwendung von Ribose zur Leistungssteigerung |
| GB9715340D0 (en) * | 1997-07-22 | 1997-09-24 | Cerestar Holding Bv | Beverages for enhanced physical performance |
-
1999
- 1999-04-12 US US09/290,789 patent/US6159942A/en not_active Expired - Lifetime
- 1999-06-17 AT AT99928759T patent/ATE534393T1/de active
- 1999-06-17 CA CA002334415A patent/CA2334415C/en not_active Expired - Lifetime
- 1999-06-17 ES ES99928759T patent/ES2374260T3/es not_active Expired - Lifetime
- 1999-06-17 JP JP2000554356A patent/JP2002518321A/ja active Pending
- 1999-06-17 NZ NZ508478A patent/NZ508478A/en unknown
- 1999-06-17 AU AU45752/99A patent/AU4575299A/en not_active Abandoned
- 1999-06-17 EP EP99928759A patent/EP1087779B1/en not_active Expired - Lifetime
- 1999-06-17 CN CN99807560A patent/CN1306431A/zh active Pending
- 1999-06-17 WO PCT/US1999/013720 patent/WO1999065476A2/en not_active Ceased
-
2010
- 2010-04-08 JP JP2010089732A patent/JP2010168394A/ja active Pending
-
2013
- 2013-08-05 JP JP2013162441A patent/JP2013237697A/ja active Pending
- 2013-11-05 JP JP2013229436A patent/JP2014043453A/ja active Pending
-
2016
- 2016-04-27 JP JP2016089312A patent/JP2016153421A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1306431A (zh) | 2001-08-01 |
| JP2013237697A (ja) | 2013-11-28 |
| EP1087779A2 (en) | 2001-04-04 |
| ES2374260T3 (es) | 2012-02-15 |
| JP2016153421A (ja) | 2016-08-25 |
| JP2002518321A (ja) | 2002-06-25 |
| US6159942A (en) | 2000-12-12 |
| NZ508478A (en) | 2003-10-31 |
| JP2014043453A (ja) | 2014-03-13 |
| ATE534393T1 (de) | 2011-12-15 |
| JP2010168394A (ja) | 2010-08-05 |
| WO1999065476A2 (en) | 1999-12-23 |
| CA2334415C (en) | 2004-08-24 |
| WO1999065476A3 (en) | 2000-04-06 |
| CA2334415A1 (en) | 1999-12-23 |
| EP1087779B1 (en) | 2011-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6159942A (en) | Compositions for increasing energy in vivo | |
| US6534480B2 (en) | Compositions for increasing energy in vivo | |
| JP6096401B2 (ja) | 筋肉の痙攣及び筋肉痛を予防するためのリボースの利用 | |
| US6429198B1 (en) | Compositions for increasing athletic performance in mammals | |
| Karlic et al. | Supplementation of L-carnitine in athletes: does it make sense? | |
| US9572882B2 (en) | Compositions and methods for improving cardiovascular function | |
| Clarkson | Nutrition for improved sports performance: current issues on ergogenic aids | |
| Figueroa et al. | L-citrulline supports vascular and muscular benefits of exercise training in older adults | |
| US20120053240A1 (en) | Method of Administering beta-hydroxy-beta-methylbutyrate (HMB) | |
| US20160303177A1 (en) | Nutritional supplement | |
| US20160303176A1 (en) | Nutritional supplement | |
| EP1313488A4 (en) | COMPOSITIONS AND METHODS FOR IMPROVING CARDIOVASCULAR FUNCTION | |
| Johnston et al. | Substrate utilization and work efficiency during submaximal exercise in vitamin C depleted-repleted adults | |
| US20050048136A1 (en) | Rehydrating beverage with Rhodiola crenulata and D-ribose that enhances blood oxygen and relieves post-exertional muscle cramping and soreness | |
| EP1745789A1 (en) | Compositions comprising ribose for increasing energy in vivo | |
| Andres et al. | A review of creatine supplementation: side effects and improvements in athletic performance | |
| CN101264093B (zh) | 用于增加体内能量的组合物 | |
| Volek | Creatine supplementation and the strength athlete | |
| Kreider et al. | Creatine: The ergogenic/anabolic supplement | |
| Romanchak et al. | Creatine Monohydrate | |
| Braverman | The Healing Nutrients Within (Volume 2 of 2)(EasyRead Large Bold Edition) | |
| Mounteer | The use of ergogenic aids in athletes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |